索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 期刊目录
  • 中国知网(CNKI)
  • 乌尔里希的期刊目录
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • 期刊摘要索引目录
  • OCLC-WorldCat
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • 谷歌学术
分享此页面
期刊传单
Flyer image

抽象的

Can Umblical Cord-Derived Mesenchymal Stem Cells be used in Retinal Diseases: A Case Presentation of Leber Congenital Amaurosis

Ayse Oner*, Neslihan Sinim Kahraman

Human umblical cord blood is an excellent source of stem and progenitor cells which increase secretion of neurotrophic factors. These cells are known to have neuroprotective effect in neurodegenerative processes. The numbers of clinical reports including implantation of stem cells in retinal diseases are increasing rapidly. This paper aimed to review the safety and efficacy of umblical cord derived mesenschymal stem cell implantation in retinal pathologies. We also present the first clinical case of a hereditary retinal disease called Lebers' congenital amaurosis with the sixth month follow-up results after stem cell treatment.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证